This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Respiratory Pathogen Testing Kits Market

Market Insights on Respiratory Pathogen Testing Kits covering sales outlook, demand forecast & up-to-date key trends

Respiratory Pathogen Testing Kits Market by Product, Infection/Symptom, Technology, End User & Region - Forecast 2022 - 2030

Respiratory Pathogen Testing Kits Market Outlook (2022-2030)

[235 Pages Report] Global consumption of respiratory pathogen testing kits is set to enjoy a valuation of US$ 3.85 Bn in 2022, and the market is slated to progress at a healthy CAGR of 6.1% to reach a valuation of US$ 6.16 Bn by 2030.

Respiratory Pathogen Testing Kits Market Size (2022)

US$ 3.85 Bn

Revenue Forecast (2030)

US$ 6.16 Bn

Global Market Growth Rate (2022-2030)

6.1% CAGR

Dominant Technology

NAAT (Nucleic Acid Amplification) (44.6% Share)

Respiratory pathogen testing kits currently account for 49.1% share in the global respiratory diagnostics market. The global respiratory pathogen kits market is predicted to rise rapidly due to an increase in the prevalence of respiratory disorders across the world.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

5.86%

H1, 2022 Projected

6.06%

H1, 2022 Outlook

5.96%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(+) 10 ↑

According to Future Market Insights' analysis, the global respiratory pathogen testing kits market expects to increase by 10 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 10 BPS.

The market for respiratory pathogen testing kits observes a decline in the BPS values with the limitations in rapid testing to not be able to evaluate common detection of coinfections. Moreover, testing kits pose limitations, such as a slow turnaround time, a labour-intensive processes, and low sensitivity.

However, with the emergence of respiratory pathogens (RP) panel tests, the market will experience an incline in terms of growth, owed to the high specificity of RP panel tests for different virus and bacteria in the respiratory tract.

The market is subject to changes as per the regulatory norms and product adoption rates, with respect to the macro and industry dynamics. The key developments in the market include the development of PCR based diagnostic test panels to detect and differentiate common respiratory pathogens simultaneously.

Respiratory Pathogen Testing Kit Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)

Sales of respiratory pathogen testing kits expanded at a rapid CAGR of 10.5% from 2015 to 2021.

By analysing blood, fluids, or a specimen from the diseased area of the body, a respiratory pathogen testing kit can be used to identify respiratory infections.

The genetic information (RNA/DNA) of some of the most prevalent infections is detected by respiratory pathogen testing kits. It can identify many bacteria that cause infection and find microbes that standard tests, such as cultures, can fail to find during testing. Some testing kits can detect microorganism subgroups or strains.

Respiratory tract blockage is caused by uncontrolled intake of various gases such as sulphur dioxide and carbon monoxide. Respiratory pathogen testing kits can diagnose a variety of bacterial, fungal, and viral infections in the respiratory system.

Lateral flow tests, also referred to as immunochromatographic assays, reverse transcription-polymerase chain reaction (RT-PCR) tests, direct fluorescent antibody (DFA) tests, solid-phase assays, agglutination assays, and flow-through assays are among the various types of respiratory pathogen testing.

Chronic Obstructive Pulmonary Disease (COPD) is a lung disease that causes a decline in airflow over time. As per WHO, low and middle-income nations account for 90% of COPD deaths.

According to the Global Burden of Disease study, around 251 million cases of chronic obstructive pulmonary disease were documented worldwide. It is predicted to rise over the coming years as the world's population ages and people's lifestyles change. Thus, as early identification and treatment are becoming necessary, the market for respiratory pathogen testing kits is expanding.

Demand for respiratory pathogen testing devices is predicted to progress at a healthy CAGR of 6.1% from 2022 to 2030, with the global market expected to close in on a valuation of US$ 6.16 Bn by 2030.

Respiratory Pathogen Testing Kits Market Download Report Brochure

Which Aspects are Positively Influencing Demand for Respiratory Pathogen Testing Kits?

“Increasing Investments in R&D Boosting Sales of Respiratory Pathogen Testing Systems”

Market growth is boosted by increased funding for respiratory diagnostics.

  • Mesa Biotech was acquired by Thermo Fisher in February 2021 in order to strengthen its Life Sciences Solutions business area. In 2021, this segment's revenue increased by almost US$ 200 million as a result of this transaction.

“Rising Incidence of Chronic Diseases Driving Consumption of Respiratory Pathogen Testing Equipment”

The respiratory pathogen testing devices market is predicted to develop due to the increased use of imaging technologies such as computed tomography (CT) in COPD diagnosis.

Use of technologically advanced equipment, such as pulse oximeters, for successful COPD care in outpatients, is quickly gaining traction. Also predicted to drive market expansion is the trend of non-invasive mechanical ventilation for COPD.

“Coronavirus Boosting Sales of Respiratory Pathogen Testing Kits”

Pneumonia, tuberculosis, bronchitis, influenza, tonsillitis, and the common cold are among the current medical disorders driving the market for respiratory pathogen testing kits. The COVID-19 pandemic has enhanced the market, since the number of covid cases continues to rise or fall at an alarming rate every day, depending on the state of health in each region.

It is critical to have respiratory pathogen testing equipment on hand to implement remedial measures within the required timeframe. Leading businesses and the respective government agencies are banding together to ensure that these kits are widely available.

“Need for Advanced Diagnostic Testing Methods Fuelling Demand for Respiratory Pathogen Testing Kits”

The diagnostic methods available to diagnose bacterial and viral illnesses in the current scenario are rapid molecular assays, antigen testing, immunofluorescence assays, vital culture, and RT-PCR (reverse transcription-polymerase chain reaction). Mylab, based in India, has developed the "PathoDetect Covid-19 Qualitative PCR kit."

This kit uses the RT-PCR method to detect infection within 2.5 hours, according to the manufacturer (as compared to 7.5 hours taken previously). This aspect is projected to boost demand for respiratory pathogen test kits in India and other Asia Pacific nations, as more infections can be discovered in much less time (considering the increasing number of incidences and population density in this region).

Staphylococcus Aureus, Moraxella Catarrhalis, Haemophilus Influenzae, and Streptococcus Pneumoniae are among the additional microorganisms that require effective respiratory pathogen testing kits. Apart from the methods stated above, multiplex PCR technology is being used since it provides fast and accurate respiratory pathogen detection.

Though viruses and bacteria account for the majority of respiratory pathogen testing kits sold, fungi also play a role. As a result, there will be an increase in demand for these kits all over the world.

"Rapid molecular assays" are a new form of molecular influenza diagnostic test with great sensitivity and specificity. NATs are used to detect certain infections (Natural Antisense Transcripts). The primary benefit of NATs is that they do not require the viability of target microorganisms and can provide data in a therapeutically relevant time range.

“Strict Laws for Mining Sector Increases Consumption of Respiratory Pathogen Testing Kits”

Because of the involuntary inhalation of silica dust, coal miners all over the world are at significant risk for non-malignant respiratory illnesses like COPD (which contains bacteria).

Nearly 53,000 people work in coal power plants in the EU, while 185,000 people work in coal mines. Regular checks of these employees are also conducted by the EU a regulatory organisation, which again increases the demand for respiratory pathogen testing kits.

In countries such as Australia, there are mining rules and regulations to check into the safety of coal miners. As part of environmental legislation, coal mining businesses must have respiratory pathogen testing kits at the workplace.

Furthermore, certain high-risk occupations, such as coal mining, are regulated by government safety regulations. As a result, these workplaces use respiratory pathogen testing kits to report workers' health quotients. This continuous demand is projected to keep the respiratory pathogen testing kits market on the rise.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Can Hinder Respiratory Pathogen Testing Kits Market Growth?

“High Product Cost & Lack of Awareness May Hamper Sales Growth of Respiratory Pathogen Testing Kits Market”

Although molecular diagnostic procedures have become an important aspect of life science research, the high cost of running molecular processes (particularly by private laboratories) may limit market growth in emerging economies. The cost of testing has risen in tandem with the advent of technological and procedural breakthroughs in biotechnology.

Patients bear the brunt of the inbound costs. As a result, global players must be on the lookout for cost-cutting opportunities. Lacks of knowledge, as well as the prevalence of a significant underdiagnosed and undertreated population, are major commercial hurdles.

Which Regional Markets are Most Profitable for Respiratory Pathogen Testing Kit Providers?

“North America Likely to Hold High Market Share Due to Rising Prevalence of Respiratory Disorders”

The most profitable markets for respiratory pathogen testing kits are still the United States and Europe. They have a combined market share of roughly 55% and are likely to maintain this trend over the coming years. Apart from Covid-19 and other existing viral, bacterial, and fungal illnesses, a sedentary lifestyle is boosting the market in these two regions.

The Asia Pacific region is also picking up steam, with a slew of local companies producing respiratory pathogen testing kits to meet the rising number of Covid-19 cases. In addition, gastrointestinal tract infections have been reported in Asia Pacific’s emerging nations, owing to people's lack of attention to food cleanliness.

Another market stimulant is air pollution. According to IQAir, Asia Pacific is home to more than 20 of the world's most polluted countries. Choking of the respiratory tract is caused by uncontrolled intake of carbon monoxide and sulphur dioxide, increasing sales of respiratory pathogen testing kits.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis                              

Why is NAAT Technology Becoming Popular in the U.S.?

“Rising Cases of Cancer & Advanced Healthcare Facilities Fuel Demand for NAAT-based Diagnostic Testing”

Because of improved healthcare infrastructure and the increased prevalence of infectious diseases, the United States is predicted to be the largest nucleic acid amplification testing market. In the United States and around the globe, NAAT is becoming the standard of practice in the blood and plasma industry.

According to cancer.org, the United States will have 1.9 Mn new cases of cancer diagnosed in 2022, with 609,360 cancer fatalities. The demand for diagnostic tests like NAAT is expanding in response to the rising cancer burden.

According to hhs.gov, Hepatitis C is projected to affect 2.4 Mn people in the United States. Hepatitis B is predicted to affect 850,000 people in the United States. The exact figure could be as higher as 4.7 Mn or as lower as 2.5 Mn. The exact figure could be anywhere from 2.2 million and 730,000.

More than half of hepatitis patients are unaware that they have the infection. As a result, individuals are at risk of developing life-threatening liver illness and cancer, as well as unwittingly spreading the virus to others.

As a result, the country's demand for better diagnostic tests is growing, and big firms and the administration are focusing on NAAT. As a result of all the factors listed above, the market for respiratory pathogen testing kits in the U.S. is predicted to rise rapidly.

How is the Respiratory Pathogen Testing Kits Market Growing in China?

“Collaboration & Partnership Tactics to Boost Sales of Respiratory Pathogen Testing Kits”

According to a Reuters investigation of research, patent filings, and other papers, BGI Group, the world's largest genomics corporation, has collaborated with China's military on projects ranging from mass testing for respiratory viruses to brain science.

BGI's linkages to the People's Liberation Army (PLA) include research with China's top military supercomputing experts, according to an assessment of more than 40 publicly available documentation and research publications in Chinese and English. The COVID-19 pandemic began in China and quickly spread over the world. Since then, the diagnostic sector has grown at a breakneck pace.

Since the beginning of the current coronavirus pandemic, China has marketed millions of COVID-19 test kits outside of the country, including to Europe, Australia, and the United States. Thus overall all the above aspects show that china is rapidly growing its respiratory pathogen testing kits business.

Category-wise Analysis

Which Technology Contributes More towards Market Growth of Respiratory Pathogen Testing Kits?

“Nucleic Acid Amplification Test Gaining Popularity Due to its Effective Result”

For SARS-CoV-2, the virus that causes COVID-19, a Nucleic Acid Amplification Test or NAAT, is a form of a viral diagnostic test. NAATs are genetic material detectors (nucleic acids). SARS-CoV-2 NAATs precisely identify the RNA (ribonucleic acid) sequences that make up the virus's genetic material.

For SARS-CoV-2 test specimens from the upper or lower respiratory tracts, NAATs are used. When testing for SARS-CoV-2, the type of specimen taken is determined by the test being conducted and the manufacturer's recommendations.

The rising prevalence of contagious diseases, increasing need for better diagnostic measures, and increased investment in the development of novel biotechnological diagnostic procedures are all driving the expansion of nucleic acid amplification testing technology. At present, nucleic acid amplification testing is expected to account for 44.6% of the global market share.

An immunoassay is a test that uses antibodies or immunoglobulin to assess the concentration of a macromolecule in a solution. Analyte refers to the macromolecule that has been detected. For medical and research reasons, immunoassay is used to determine the number of solutes in serum and urine. It is also used to check the correctness of results acquired in qualitative, quantitative, and radioactive procedures. Immunoassays with diagnostic accuracy are utilised to accelerate the rate of reaction.

Increasing prevalence of chronic and infectious diseases, as well as the usage of immunoassays in oncology, is driving the global immunoassay trade forward. In addition, immunoassays technological breakthroughs and sensitivity, cost-effectiveness, and speedy analysis contribute to their rise.

In 2022, immunoassays technology is predicted to hold 31.3% of the global market share, while other technologies are likely to account for 24.1% of the global market share.

Competitive Landscape

Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Hoffmann-La Roche Ltd., bioMérieux Inc., Altona Diagnostics, and MyLab are some of the major participants in the respiratory pathogen testing kits market.

Leading respiratory pathogen testing equipment manufacturers are concentrating their efforts on developing unique testing kits that will aid in obtaining results quickly. They're investing heavily to get a competitive advantage over one another.

New products are being introduced into the respiratory pathogen testing kits market, as well as expansion into new geographies.

  • Philips expanded its ultrasound offering with additional strong imaging tools and features for Radiology in November 2021, boosting diagnostic assurance and workflow efficiency.

Respiratory Pathogen Testing Kits Industry Report Scope

Attribute

Details

Forecast Period

2022-2030

Historical Data Available for

2015-2021

Market Analysis

US$ Bn for Value, Units for Volume

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Product
  • Infection/Symptom
  • Technology
  • End User
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments of Respiratory Pathogen Testing Kits Industry Survey

Respiratory Pathogen Testing Kits Market by Product:

  • RT PCR Kits
  • DFA Kits
  • ELISA Kits
  • Others

Respiratory Pathogen Testing Kits Market by Infection/Symptom:

  • Matrix
  • Enterovirus Infection
  • Human Coronavirus Infection
  • Influenza Virus Infection
  • Respiratory Syncytial Virus Infection
  • Rhinovirus Infection
  • Pneumonia

Respiratory Pathogen Testing Kits Market by Technology:

  • NAAT (Nucleic Acid Amplification)
  • Immunoassays
  • Others

Respiratory Pathogen Testing Kits Market by End User:

  • Hospitals
  • Diagnostic Centers
  • Speciality Clinics

Respiratory Pathogen Testing Kits Market by Region:

  • North America Respiratory Pathogen Testing Kits Market
  • Latin America Respiratory Pathogen Testing Kits Market
  • Europe Respiratory Pathogen Testing Kits Market
  • East Asia Respiratory Pathogen Testing Kits Market
  • South Asia & Pacific Respiratory Pathogen Testing Kits Market
  • Middle East & Africa (MEA) Respiratory Pathogen Testing Kits Market

Frequently Asked Questions

The global respiratory pathogen testing kits market is estimated to expand at a CAGR of 6.1% through 2030.

The global respiratory pathogen testing kits market is currently worth US$ 3.85 Bn.

Key respiratory pathogen testing kit manufacturers are Thermo Fisher Scientific, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Hoffmann-La Roche Ltd., bioMérieux Inc., Altona Diagnostics, and MyLab.

By 2030, respiratory pathogen testing kit demand is anticipated to reach a valuation of US$ 6.16 Bn.

Market growth is being witnessed due to factors such as rising prevalence of chronic and respiratory disorders, as well as increasing investments in research and development activities in this field.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Development Trends

4. Key Success Factors

    4.1. New Product Launches

    4.2. Key Strategies Followed By Manufacturers

    4.3. Pipeline Assessment & Opportunity Analysis 

5. Market Context

    5.1. Epidemiology of Severe Acute Respiratory Syndrome, By Country

    5.2. Regulatory Scenario

    5.3. Product Adoption / Usage Analysis

    5.4. Reimbursement Scenario

    5.5. Pipeline Analysis

    5.6. Value Chain Analysis

    5.7. Global Average Pricing Analysis Benchmark

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product

        6.4.2. Revenue By Indications

        6.4.3. Revenue By Country

    6.5. 2022 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Respiratory Pathogen Testing Market Demand Analysis 2015-2021`` and Forecast, 2022-2030

    7.1. Historical Market Volume (Units) Analysis, 2015-2021``

    7.2. Current and Future Market Volume (Units) Projections, 2022-2030

    7.3. Y-o-Y Growth Trend Analysis

8. Global Respiratory Pathogen Testing Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product Type

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Respiratory Pathogen Testing Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030

    9.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Market Background

    10.1. Macro-Economic Factors

        10.1.1. Global GDP Growth Outlook

        10.1.2. Global Healthcare Outlook

        10.1.3. Per Capita Healthcare Expenditure Outlook

    10.2. Forecast Factors - Relevance & Impact

        10.2.1. Increasing Incidence of Respiratory Infections

        10.2.2. Recent Outbreak of Corona Virus

        10.2.3. Increasing Healthcare Expenditure

        10.2.4. Growing Demand of Treatment

    10.3. Market Dynamics

        10.3.1. Drivers

        10.3.2. Restraints

        10.3.3. Opportunity Analysis

11. Global Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030, By Products 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Products, 2015–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Products, 2022-2030

        11.3.1. RT PCR kits 

        11.3.2. DFA Kits

        11.3.3. ELISA Kits 

        11.3.4. Others 

        11.3.5. Market Attractiveness Analysis By Products

12. Global Respiratory Pathogen Testing Market Analysis 2015-2021`` and Forecast 2022-2030, by Indications

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) and Analysis By Indications, 2015 - 2021``

    12.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Indications, 2022- 2030

        12.3.1. Enterovirus Infection

        12.3.2. Human Coronavirus Infection

        12.3.3. Influenza  Virus Infection

        12.3.4. Respiratory Syncytial Virus Infection

        12.3.5. Rhinovirus Infection

        12.3.6. Pneumonia

        12.3.7. Others

    12.4. Market Attractiveness Analysis By Indications

13. Global Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Technology

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) and Analysis By Technology, 2015 - 2021``

    13.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Technology, 2022 - 2030

        13.3.1. NAAT (Nucliec Acid Amplification)

        13.3.2. Immunoassay

        13.3.3.  Others

    13.4. Market Attractiveness Analysis By Technology

14. Global Respiratory Pathogen Testing Market Analysis 2015-2021`` and Forecast 2022-2030, by End User

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) and Analysis By End User, 2015 - 2021``

    14.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By End User, 2022 - 2030

        14.3.1. Hospitals

        14.3.2. Diagnostic Centers

        14.3.3. Speciality Clinics

    14.4. Market Attractiveness Analysis By End User

15. Global Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Region

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030

        15.3.1. North America

        15.3.2. Latin America

        15.3.3. Europe

        15.3.4. East Asia

        15.3.5. South Asia

        15.3.6. Oceania

        15.3.7. Middle East and Africa (MEA)

    15.4. Market Attractiveness Analysis By Region

16. North America Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        16.3.1.  By Country

            16.3.1.1. U.S.

            16.3.1.2. Canada

        16.3.2. By Products

        16.3.3. By Technique

        16.3.4. By Indications

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Products

        16.4.3. By Technique

        16.4.4. By Indications

        16.4.5. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

17. Latin America Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        17.3.1.  By Country

            17.3.1.1. Brazil

            17.3.1.2. Mexico

            17.3.1.3. Argentina

            17.3.1.4. Rest of Latin America

        17.3.2. By Products

        17.3.3. By Technique

        17.3.4. By Strain

        17.3.5. By Indications

        17.3.6. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Products

        17.4.3. By Technique

        17.4.4. By Indications

        17.4.5. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

18. Europe Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn)  Analysis By Market Taxonomy, 2015–2021

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        18.3.1.  By Country

            18.3.1.1. Germany

            18.3.1.2. Italy

            18.3.1.3. France

            18.3.1.4. U.K.

            18.3.1.5. Spain

            18.3.1.6. BENELUX

            18.3.1.7. Russia

            18.3.1.8. Rest of Europe

        18.3.2. By Products

        18.3.3. By Technique

        18.3.4. By Indications

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Products

        18.4.3. By Technique

        18.4.4. By Indications

        18.4.5. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

19. South Asia Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn)  Analysis By Market Taxonomy, 2015–2021

    19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        19.3.1.  By Country

            19.3.1.1. India

            19.3.1.2. Thailand

            19.3.1.3. Indonesia

            19.3.1.4. Malaysia

            19.3.1.5. Rest of South Asia

        19.3.2. By Products

        19.3.3. By Technique

        19.3.4. By Indications

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Products

        19.4.3. By Technique

        19.4.4. By Indications

        19.4.5. By End User

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

20. East Asia Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn)  Analysis By Market Taxonomy, 2015–2021

    20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        20.3.1.  By Country

            20.3.1.1. China

            20.3.1.2. Japan

            20.3.1.3. South Korea

        20.3.2. By Products

        20.3.3. By Technique

        20.3.4. By Indications

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Products

        20.4.3. By Technique

        20.4.4. By Indications

        20.4.5. By End User

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

21. Oceania Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    21.3. Current and Future Market Size (US$ Mn)  Analysis and Forecast By Market Taxonomy, 2022-2030

        21.3.1.  By Country

            21.3.1.1. Australia

            21.3.1.2. New Zealand

        21.3.2. By Products

        21.3.3. By Technique

        21.3.4. By Indications

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Country

        21.4.2. By Products

        21.4.3. By Technique

        21.4.4. By Indications

        21.4.5. By End User

    21.5. Market Trends

    21.6. Key Market Participants - Intensity Mapping

    21.7. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    22.1. Introduction

    22.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    22.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        22.3.1.  By Country

            22.3.1.1. GCC Countries

            22.3.1.2. Turkey

            22.3.1.3. Northern Africa

            22.3.1.4. South Africa

            22.3.1.5. Rest of Middle East and Africa

        22.3.2. By Products

        22.3.3. By Technique

        22.3.4. By Indications

        22.3.5. By End User

    22.4. Market Attractiveness Analysis

        22.4.1. By Country

        22.4.2. By Products

        22.4.3. By Technique

        22.4.4. By Indications

        22.4.5. By End User

    22.5. Market Trends

    22.6. Key Market Participants - Intensity Mapping

    22.7. Drivers and Restraints - Impact Analysis

23. Key and Emerging Countries Respiratory Pathogen Testing Market Analysis 2015-2021 and Forecast 2022-2030

    23.1. Introduction

        23.1.1. Market Value Proportion Analysis, By Key Countries

        23.1.2. Global Vs. Country Growth Comparison

    23.2. U.S. Respiratory Pathogen Testing Market Analysis

        23.2.1. By Products

        23.2.2. By Technique

        23.2.3. By Indications

        23.2.4. By End User

    23.3. Canada Respiratory Pathogen Testing Market Analysis

        23.3.1. By Products

        23.3.2. By Technique

        23.3.3. By Indications

        23.3.4. By End User

    23.4. Mexico Respiratory Pathogen Testing Market Analysis

        23.4.1. By Products

        23.4.2. By Technique

        23.4.3. By Indications

        23.4.4. By End User

    23.5. Brazil Respiratory Pathogen Testing Market Analysis

        23.5.1. By Products

        23.5.2. By Technique

        23.5.3. By Indications

        23.5.4. By End User

    23.6. U.K. Respiratory Pathogen Testing Market Analysis

        23.6.1. By Products

        23.6.2. By Technique

        23.6.3. By Indications

        23.6.4. By End User

    23.7. Germany Respiratory Pathogen Testing Market Analysis

        23.7.1. By Products

        23.7.2. By Technique

        23.7.3. By Indications

        23.7.4. By End User

    23.8. France Respiratory Pathogen Testing Market Analysis

        23.8.1. By Products

        23.8.2. By Technique

        23.8.3. By Indications

        23.8.4. By End User

    23.9. Italy Respiratory Pathogen Testing Market Analysis

        23.9.1. By Products

        23.9.2. By Technique

        23.9.3. By Indications

        23.9.4. By End User

    23.10. Spain Respiratory Pathogen Testing Market Analysis

        23.10.1. By Products

        23.10.2. By Technique

        23.10.3. By Indications

        23.10.4. By End User

    23.11. Russia Respiratory Pathogen Testing Market Analysis

        23.11.1. By Products

        23.11.2. By Technique

        23.11.3. By Indications

        23.11.4. By End User

    23.12. China Respiratory Pathogen Testing Market Analysis

        23.12.1. By Products

        23.12.2. By Technique

        23.12.3. By Indications

        23.12.4. By End User

    23.13. Japan Respiratory Pathogen Testing Market Analysis

        23.13.1. By Products

        23.13.2. By Technique

        23.13.3. By Indications

        23.13.4. By End User

    23.14. South Korea Respiratory Pathogen Testing Market Analysis

        23.14.1. By Products

        23.14.2. By Technique

        23.14.3. By Indications

        23.14.4. By End User

    23.15. India Respiratory Pathogen Testing Market Analysis

        23.15.1. By Products

        23.15.2. By Technique

        23.15.3. By Indications

        23.15.4. By End User

    23.16. ASEAN Respiratory Pathogen Testing Market Analysis

        23.16.1. By Products

        23.16.2. By Technique

        23.16.3. By Indications

        23.16.4. By End User

    23.17. Australia Respiratory Pathogen Testing Market Analysis

        23.17.1. By Products

        23.17.2. By Technique

        23.17.3. By Indications

        23.17.4. By End User

    23.18. New Zealand Respiratory Pathogen Testing Market Analysis

        23.18.1. By Products

        23.18.2. By Technique

        23.18.3. By Indications

        23.18.4. By End User

    23.19. GCC Countries Respiratory Pathogen Testing Market Analysis

        23.19.1. By Products

        23.19.2. By Technique

        23.19.3. By Indications

        23.19.4. By End User

    23.20. South Africa Respiratory Pathogen Testing Market Analysis

        23.20.1. By Products

        23.20.2. By Technique

        23.20.3. By Indications

        23.20.4. By End User

24. Market Structure Analysis

    24.1. Market Analysis by Tier of Companies

    24.2. Market Share Analysis 

    24.3. Market Presence Analysis

        24.3.1. By Regional footprint of Players

        24.3.2. Product foot print by Players

        24.3.3. Channel Foot Print by Players

25. Competition Analysis

    25.1. Competition Dashboard

    25.2. Competition Benchmarking

    25.3. Competition Deep Dive (Tentative List)

        25.3.1. Hoffmann-La Roche Inc.

            25.3.1.1. Overview

            25.3.1.2. Product Portfolio

            25.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.1.4. Sales Footprint

            25.3.1.5. Strategy Overview

                25.3.1.5.1. Marketing Strategy

                25.3.1.5.2. Product Strategy

                25.3.1.5.3. Channel Strategy

        25.3.2. Seegene Inc

            25.3.2.1. Overview

            25.3.2.2. Product Portfolio

            25.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.2.4. Sales Footprint

            25.3.2.5. Strategy Overview

                25.3.2.5.1. Marketing Strategy

                25.3.2.5.2. Product Strategy

                25.3.2.5.3. Channel Strategy

        25.3.3. Fast Track Diagnostics Ltd

            25.3.3.1. Overview

            25.3.3.2. Product Portfolio

            25.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.3.4. Sales Footprint

            25.3.3.5. Strategy Overview

                25.3.3.5.1. Marketing Strategy

                25.3.3.5.2. Product Strategy

                25.3.3.5.3. Channel Strategy

        25.3.4. PathoFinder BV

            25.3.4.1. Overview

            25.3.4.2. Product Portfolio

            25.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.4.4. Sales Footprint

            25.3.4.5. Strategy Overview

                25.3.4.5.1. Marketing Strategy

                25.3.4.5.2. Product Strategy

                25.3.4.5.3. Channel Strategy

        25.3.5. Daan Gene Co Ltd

            25.3.5.1. Overview

            25.3.5.2. Product Portfolio

            25.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.5.4. Sales Footprint

            25.3.5.5. Strategy Overview

                25.3.5.5.1. Marketing Strategy

                25.3.5.5.2. Product Strategy

                25.3.5.5.3. Channel Strategy

        25.3.6. Veredus Laboratories Pte Ltd

            25.3.6.1. Overview

            25.3.6.2. Product Portfolio

            25.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.6.4. Sales Footprint

            25.3.6.5. Strategy Overview

                25.3.6.5.1. Marketing Strategy

                25.3.6.5.2. Product Strategy

                25.3.6.5.3. Channel Strategy

        25.3.7. True Health Diagnostics LLC

            25.3.7.1. Overview

            25.3.7.2. Product Portfolio

            25.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.7.4. Sales Footprint

            25.3.7.5. Strategy Overview

                25.3.7.5.1. Marketing Strategy

                25.3.7.5.2. Product Strategy

                25.3.7.5.3. Channel Strategy

        25.3.8. Genetic Signatures Ltd

            25.3.8.1. Overview

            25.3.8.2. Product Portfolio

            25.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.8.4. Sales Footprint

            25.3.8.5. Strategy Overview

                25.3.8.5.1. Marketing Strategy

                25.3.8.5.2. Product Strategy

                25.3.8.5.3. Channel Strategy

        25.3.9. Beijing Baicare BioTechnique Co Ltd

            25.3.9.1. Overview

            25.3.9.2. Product Portfolio

            25.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.9.4. Sales Footprint

            25.3.9.5. Strategy Overview

                25.3.9.5.1. Marketing Strategy

                25.3.9.5.2. Product Strategy

                25.3.9.5.3. Channel Strategy

        25.3.10. Cue Health Inc

            25.3.10.1. Overview

            25.3.10.2. Product Portfolio

            25.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.10.4. Sales Footprint

            25.3.10.5. Strategy Overview

                25.3.10.5.1. Marketing Strategy

                25.3.10.5.2. Product Strategy

                25.3.10.5.3. Channel Strategy

        25.3.11. Siemens Healthineers AG

            25.3.11.1. Overview

            25.3.11.2. Product Portfolio

            25.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.11.4. Sales Footprint

            25.3.11.5. Strategy Overview

                25.3.11.5.1. Marketing Strategy

                25.3.11.5.2. Product Strategy

                25.3.11.5.3. Channel Strategy

        25.3.12. Abbott Laboratories

            25.3.12.1. Overview

            25.3.12.2. Product Portfolio

            25.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.12.4. Sales Footprint

            25.3.12.5. Strategy Overview

                25.3.12.5.1. Marketing Strategy

                25.3.12.5.2. Product Strategy

                25.3.12.5.3. Channel Strategy

        25.3.13. Sysmex Corp

            25.3.13.1. Overview

            25.3.13.2. Product Portfolio

            25.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.13.4. Sales Footprint

            25.3.13.5. Strategy Overview

                25.3.13.5.1. Marketing Strategy

                25.3.13.5.2. Product Strategy

                25.3.13.5.3. Channel Strategy

        25.3.14. Beckman Coulter Inc

            25.3.14.1. Overview

            25.3.14.2. Product Portfolio

            25.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.14.4. Sales Footprint

            25.3.14.5. Strategy Overview

                25.3.14.5.1. Marketing Strategy

                25.3.14.5.2. Product Strategy

                25.3.14.5.3. Channel Strategy

        25.3.15. Danaher Corp

            25.3.15.1. Overview

            25.3.15.2. Product Portfolio

            25.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.15.4. Sales Footprint

            25.3.15.5. Strategy Overview

                25.3.15.5.1. Marketing Strategy

                25.3.15.5.2. Product Strategy

                25.3.15.5.3. Channel Strategy

        25.3.16. Bio-Rad Laboratories Inc

            25.3.16.1. Overview

            25.3.16.2. Product Portfolio

            25.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.16.4. Sales Footprint

            25.3.16.5. Strategy Overview

                25.3.16.5.1. Marketing Strategy

                25.3.16.5.2. Product Strategy

                25.3.16.5.3. Channel Strategy

        25.3.17. Thermo Fisher Scientific Inc

            25.3.17.1. Overview

            25.3.17.2. Product Portfolio

            25.3.17.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.17.4. Sales Footprint

            25.3.17.5. Strategy Overview

                25.3.17.5.1. Marketing Strategy

                25.3.17.5.2. Product Strategy

                25.3.17.5.3. Channel Strategy

        25.3.18. Qiagen NV

            25.3.18.1. Overview

            25.3.18.2. Product Portfolio

            25.3.18.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.18.4. Sales Footprint

            25.3.18.5. Strategy Overview

                25.3.18.5.1. Marketing Strategy

                25.3.18.5.2. Product Strategy

                25.3.18.5.3. Channel Strategy

        25.3.19. bioMerieux SA

            25.3.19.1. Overview

            25.3.19.2. Product Portfolio

            25.3.19.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.19.4. Sales Footprint

            25.3.19.5. Strategy Overview

                25.3.19.5.1. Marketing Strategy

                25.3.19.5.2. Product Strategy

                25.3.19.5.3. Channel Strategy

        25.3.20. Horiba Ltd

            25.3.20.1. Overview

            25.3.20.2. Product Portfolio

            25.3.20.3. Profitability by Market Segments (Product/Channel/Region)

            25.3.20.4. Sales Footprint

            25.3.20.5. Strategy Overview

                25.3.20.5.1. Marketing Strategy

                25.3.20.5.2. Product Strategy

                25.3.20.5.3. Channel Strategy

26. Assumptions and Acronyms Used

27. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 02: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 03: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 04: Global Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Region

Table 05: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 06: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 07: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 08: North America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 09: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 10: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 11: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 12: Latin America Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 13: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 14: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 15: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 16: Europe Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 17: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 18: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 19: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 20: South Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 21: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 22: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 23: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 24: East Asia Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 25: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 26: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 27: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 28: Oceania Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Table 29: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Country

Table 30: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Product Type

Table 31: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By Indication

Table 32: Middle East & Africa Respiratory Pathogen Testing kits Market Size (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 02: Global Respiratory Pathogen Testing kits Market Share, By Product Type (2021)

Figure 03: Global Respiratory Pathogen Testing kits Market Share, By Indication (2021)

Figure 04: Global Respiratory Pathogen Testing kits Market Share, By End User (2021)

Figure 05: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By Product Type, 2022–2030

Figure 06: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 07: Global Respiratory Pathogen Testing kits Market Share Analysis (%), By Indication, 2022 & 2030

Figure 08: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By Indication, 2022–2030

Figure 09: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 10: Global Respiratory Pathogen Testing kits Market Share Analysis (%), By End User, 2022 & 2030

Figure 11: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By End User, 2022–2030

Figure 12: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 13: Global Respiratory Pathogen Testing kits Market Share Analysis (%), By Region Type, 2022 & 2030

Figure 14: Global Respiratory Pathogen Testing kits Market Y-o-Y Analysis (%), By Region Type, 2022–2030

Figure 15: Global Respiratory Pathogen Testing kits Market Attractiveness Analysis By Region, 2022–2030

Figure 16: North America Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 17: North America Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 18: North America Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 19: North America Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 20: North America Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 21: North America Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 22: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 23: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 24: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 25: North America Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 26: Latin America Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 27: Latin America Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 28: Latin America Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 29: Latin America Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 30: Latin America Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 31: Latin America Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 32: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 33: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 34: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 35: Latin America Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 36: Europe Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 37: Europe Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 38: Europe Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 39: Europe Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 40: Europe Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 41: Europe Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 42: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 43: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 44: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 45: Europe Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 46: South Asia Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 47: South Asia Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 48: South Asia Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 49: South Asia Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 50: South Asia Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 51: South Asia Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 52: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 53: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 54: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 55: South Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 56: East Asia Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 57: East Asia Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 58: East Asia Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 59: East Asia Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 60: East Asia Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 61: East Asia Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 62: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 63: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 64: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 65: East Asia Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 66: Oceania Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 67: Oceania Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 68: Oceania Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 69: Oceania Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 70: Oceania Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 71: Oceania Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 72: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 73: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 74: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 75: Oceania Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 76: Middle East & Africa Respiratory Pathogen Testing kits Market Split By Country 2022 (E)

Figure 77: Middle East & Africa Respiratory Pathogen Testing kits Market Split By Product Type 2022 (E)

Figure 78: Middle East & Africa Respiratory Pathogen Testing kits Market Split By Indication 2022 (E)

Figure 79: Middle East & Africa Respiratory Pathogen Testing kits Market Split By End User 2022 (E)

Figure 80: Middle East & Africa Respiratory Pathogen Testing kits Market Value Analysis (US$ Mn), 2015–2021

Figure 81: Middle East & Africa Respiratory Pathogen Testing kits Market Value Forecast (US$ Mn), 2022–2030

Figure 82: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By Country, 2022–2030

Figure 83: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By Product Type, 2022–2030

Figure 84: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By Indication, 2022–2030

Figure 85: Middle East & Africa Respiratory Pathogen Testing kits Market Attractiveness Analysis By End User, 2022–2030

Figure 86: U.S Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 87: U.S. Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 88: U.S. Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 89: U.S. Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 90: Global Vs. U.S Growth Comparison

Figure 91: Canada Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 92: Canada  Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 93: Canada Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 94: Canada Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 95: Global Vs. Canada Growth Comparison

Figure 96: Brazil Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 97: Brazil Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 98: Brazil Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 99: Brazil Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 100: Global Vs. Brazil Growth Comparison

Figure 101: Mexico Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 102: Mexico Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 103: Mexico Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 104: Mexico Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 105: Global Vs. Mexico Growth Comparison

Figure 106: U.K. Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 107: U.K. Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 108: U.K. Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 109: U.K. Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 110: Global Vs. U.K. Growth Comparison

Figure 111: Germany Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 112: Germany Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 113: Germany Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 114: Germany Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 115: Global Vs. Germany Growth Comparison

Figure 116: France Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 117: France Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 118: France Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 119: France Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 120: Global Vs. France Growth Comparison

Figure 121: Italy Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 122: Italy Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 123: Italy  Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 124: Italy Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 125: Global Vs. Italy Growth Comparison

Figure 126: Spain Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 127: Spain Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 128: Spain Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 129: Spain Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 130: Global Vs. Spain Growth Comparison

Figure 131: Russia Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 132: Russia Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 133: Russia Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 134: Russia Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 135: Global Vs. Russia Growth Comparison

Figure 136: Japan Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 137: Japan Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 138: Japan Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 139: Japan Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 140: Global Vs. Japan Growth Comparison

Figure 141: South Korea Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 142: South Korea Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 143: South Korea Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 144: South Korea Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 145: Global Vs. South Korea Growth Comparison

Figure 146: India Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 147: India Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 148: India Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 149: India Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 150: Global Vs. India Growth Comparison

Figure 151: Australia Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 152: Australia Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 153: Australia Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 154: Australia Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 155: Global Vs. Australia Growth Comparison

Figure 156: New Zealand Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 157: New Zealand Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 158: New Zealand Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 159: New Zealand Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 160: Global Vs. New Zealand Growth Comparison

Figure 161: GCC Countries Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 162: GCC Countries Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 163: GCC Countries Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 164: GCC Countries Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 165: Global Vs. GCC Countries Growth Comparison

Figure 166: Turkey Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 167: Turkey Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 168: Turkey Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 169: Turkey Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 170: Global Vs. Turkey Growth Comparison

Figure 171: South Africa Respiratory Pathogen Testing kits Market Value Proportion Analysis

Figure 172: South Africa Respiratory Pathogen Testing kits Market Share Analysis (%) By Indication, 2022 & 2030

Figure 173: South Africa Respiratory Pathogen Testing kits Market Share Analysis (%) By Product Type, 2022 & 2030

Figure 174: South Africa Respiratory Pathogen Testing kits Market Share Analysis (%) By End User, 2022 & 2030

Figure 175: Global Vs. South Africa Growth Comparison

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Therapeutic Respiratory Devices Market

Published : March 2022

Healthcare

Respiratory Pathogen Testing Kits Market

Published : June 2020

Healthcare

At-Home Vaginal pH Test Kit Market

Published : January 2019

Healthcare

Swine Respiratory Diseases Treatment Market

Published : December 2017

Google translate

Respiratory Pathogen Testing Kits Market